Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-04

Clinical Trial Update: Tzanck Smear With Methylene Blue Stain for Herpes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Tzanck smear with methylene blue stain for herpes diagnosis is currently in unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chulalongkorn University | Conditions: Herpes Simplex, Herpes Zoster | Phase 3 | Status: UNKNOWN